mRNA-3745

ModernaTX, Inc. · Phase 1 active Small molecule

At a glance

Generic name	mRNA-3745
Sponsor	ModernaTX, Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Study of mRNA-3745 in Adult and Pediatric Participants With Glycogen Storage Disease Type 1a (GSD1a) (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

mRNA-3745 CI brief — competitive landscape report
mRNA-3745 updates RSS · CI watch RSS
ModernaTX, Inc. portfolio CI